Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

585
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
585
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

459
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
459

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A non-invasive and simple method to assess incomplete aortic cross-clamping during cardiovascular surgery with cardiopulmonary bypass.

General thoracic and cardiovascular surgeryยท2026
Same author

Untreated mild-moderate mitral regurgitation after isolated aortic valve replacement for aortic stenosis.

Journal of cardiothoracic surgeryยท2026
Same author

Echographic assessment of visceral perfusion under intra-aortic balloon pump support.

Journal of critical careยท2026
Same author

Objective analysis of frailty-based 10-year outcomes of transcatheter and surgical aortic valve replacement.

JTCVS structural and endovascularยท2026
Same author

Early Dynamic Changes in Haematoma Thickness in Medically Managed Type A Intramural Haematoma: A Multicentre Retrospective Study.

Interdisciplinary cardiovascular and thoracic surgeryยท2026
Same author

Effect of diuretic burden and model for end-stage liver disease-sodium score after isolated tricuspid valve surgery.

Journal of thoracic diseaseยท2026

Related Experiment Video

Updated: Apr 4, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

Minimally Invasive Transaortic Mitral Decalcification During Aortic Valve Replacement.

Toshinori Totsugawa1, Taichi Sakaguchi, Arudo Hiraoka

  • 1From the Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Innovations (Philadelphia, Pa.)
|September 11, 2015
PubMed
Summary

Minimally invasive mitral decalcification during aortic valve replacement is a feasible option for high-risk patients with severe mitral annular calcification and aortic stenosis, reducing operative risks.

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.9K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Related Experiment Videos

Last Updated: Apr 4, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.9K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Severe mitral annular calcification (MAC) combined with aortic stenosis (AS) poses significant risks for standard valve replacement procedures.
  • High-risk patients often face prohibitive risks with conventional double-valve replacement or transcatheter aortic valve implantation.

Observation:

  • A novel minimally invasive approach for mitral decalcification during aortic valve replacement was performed via minithoracotomy.
  • This technique addresses the challenges presented by severe MAC in patients undergoing aortic valve surgery.

Findings:

  • Minimally invasive transaortic mitral decalcification concurrent with aortic valve replacement is technically feasible.
  • This approach offers a potentially safer alternative for patients with severe MAC and AS.

Implications:

  • This technique may reduce operative risks in high-risk patients with complex valve disease.
  • It expands the options for managing severe MAC and AS, particularly in patients unsuitable for standard or TAVI procedures.